Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.

Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...

A doctor from the University of Palermo in Italy has published a case study of an adult cocaine user who experienced reduced ...

Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. Key Points ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...

The results come just a few weeks after a once-weekly injectable GLP-1 drug CT-388 – also sourced from Carmot – achieved an average weight loss of 18.8% at 24 weeks in a phase 1b trial ...

Sky-high demand, a high price tag and tight supplies have created opportunities for bad actors to take advantage of consumers ...

Millions of Americans rely on GLP-1 drugs to improve their health, but bad actors are peddling dangerous fakes.” ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...